姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
He,Jun-Xian | Chairman | 4.37% | |
Wang,Shi-Zong | Director | 4.24% | |
Chen,Hong-Yao | Director | 3.39% | |
Zheng,Jin-Hong | Director | 5.39% | |
Huang,Shi-Yi | Independent Director | 0.00% | |
Wu,Li-Qing | Independent Director | 0.00% | |
Xu,Yong-Zhen | Independent Director | 0.00% |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Operating income | 828,723 | 3,420,294 | 3,642,580 |
Operating cost | 727,024 | 2,998,312 | 3,279,021 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 101,699 | 421,982 | 363,559 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 101,699 | 421,982 | 363,559 |
Operating expenses | 138,073 | 654,806 | 724,379 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | -36,374 | -232,824 | -360,820 |
Non-operating income and expenses | 4,548 | 71,110 | 5,882 |
Net profit (loss) before tax | -31,826 | -161,714 | -354,938 |
Income tax expense (benefits) | -2,862 | 16,355 | 7,669 |
Net profit (loss) of ongoing business for the current period | -28,964 | -178,069 | -362,607 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | -28,964 | -178,069 | -362,607 |
Other comprehensive profit (loss), net | 42,700 | 147,563 | -42,474 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 13,736 | -30,506 | -405,081 |
Net profit (loss) attributable to owners of parent company | -27,923 | -176,144 | -362,509 |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | -1,041 | -1,925 | -98 |
Comprehensive profit (loss) attributable to owners of parent company | 14,466 | -30,198 | -404,833 |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | -730 | -308 | -248 |
Basic earnings per share (yuan) | 0 | -2 | -4 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | -58,236 | -154,892 | 71,898 |
Net cash inflows (outflows) from investing activities | -8,465 | -216,039 | -376,590 |
Net cash inflow (outflow) from financing activities | -77,534 | 30,077 | 161,511 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 43,011 | 144,287 | -45,964 |
Increase (decrease) in cash and cash equivalents in the current period | -101,224 | -196,567 | -189,145 |
Beginning balance of cash and cash equivalents | 879,109 | 1,075,676 | 1,264,821 |
Ending balance of cash and cash equivalents | 777,885 | 879,109 | 1,075,676 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Current asset | 2,587,449 | 2,690,234 | 2,736,368 |
Non-current asset | 1,607,714 | 1,617,209 | 1,499,915 |
Total asset | 4,195,163 | 4,307,443 | 4,236,283 |
Current liability | 1,340,019 | 1,490,078 | 2,341,467 |
Non-current liability | 1,367,981 | 1,343,938 | 403,899 |
Total liability | 2,708,000 | 2,834,016 | 2,745,366 |
share capital | 875,500 | 875,500 | 875,500 |
Equity - secruity token | - | - | - |
capital reserve | 380,455 | 380,455 | 380,455 |
retained earning | 319,515 | 347,438 | 520,911 |
Other equity | -109,786 | -152,175 | -295,450 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | 1,465,684 | 1,451,218 | 1,481,416 |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | 21,479 | 22,209 | 9,501 |
Total Equity | 1,487,163 | 1,473,427 | 1,490,917 |
Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 16 | 16 | 16 |